At a glance
ClinicalIndex Comparison RecordN/ACompleted· 64 enrolled
Drug / intervention
Chewable aspirinother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Validation of an Ex Vivo Cyclooxygenase-1 Catalytic Assay in Humans
In Brief
A clinical study evaluating Chewable aspirin for Healthy. Completed, enrolled 64 participants across 1 site.
Detailed Summary
The purpose of this study is to obtain a reference range for a newly developed assay of ex vivo platelet COX-1 activity in normal volunteers taking a routine clinical dose of aspirin.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMay 2007
Primary CompletionMay 2008
First PostedSep 2008
Study CompletionJan 2010
TodayJul 2026
First PostedSep 30, 2008
Enrollment StartMay 1, 2007
Primary CompletionMay 1, 2008
Study CompletionJan 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 17.8 years ago
Interventions
Chewable aspirinother
chewable aspirin 81mg daily for 2 weeks